Recruiting Ankylosing Spondylitis Studies in Kobe
About Ankylosing Spondylitis Clinical Trials in Kobe
Ankylosing spondylitis is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints, causing pain, stiffness, and potentially spinal fusion. It typically begins in early adulthood. Treatment includes NSAIDs, biologics (TNF and IL-17 inhibitors), and physical therapy.
There are currently 1 ankylosing spondylitis clinical trials recruiting participants in Kobe, HY%C5%8DGO. These studies are seeking a combined 126 participants. Research is being sponsored by Novartis Pharmaceuticals. Clinical trial participation is free and participants receive study-related medical care at no cost.
Ankylosing Spondylitis Clinical Trials in Kobe — FAQ
Are there ankylosing spondylitis clinical trials in Kobe?
Yes, there are 1 ankylosing spondylitis clinical trials currently recruiting in Kobe, HY%C5%8DGO. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Kobe?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Kobe research site will contact you about next steps.
Are clinical trials in Kobe free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Kobe studies also compensate for your time and travel.
What ankylosing spondylitis treatments are being tested?
The 1 active trials in Kobe are testing new therapies including novel drugs, biologics, and treatment approaches for ankylosing spondylitis.
Data updated March 2, 2026 from ClinicalTrials.gov